Tim Lohoff
CIK: 0002142007
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BRVE
Braveheart Bio, Inc.
Director
Discretionary Trading P&L
Holdings
About Lohoff Tim
Lohoff Tim (SEC CIK 0002142007) files insider reports with the SEC as Director of Braveheart Bio, Inc. (BRVE).
Signal8 holds 2 ownership filings by Lohoff Tim (1 Form 3, 1 Form 4), filed between Aug 5, 2026 and Aug 7, 2026. Those filings report 1 transaction, the latest on Aug 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lohoff Tim's filings is in SAN FRANCISCO, CA.
Recent filings by Lohoff Tim
- Aug 5, 2026: Grant or award of BRVE derivative securities (Form 4, code A).
Other insiders filing for Braveheart Bio, Inc. (BRVE)
- Agarwala Vineeta, Director
- AH Bio Fund IV, L.P., 10% Owner
- Chimovits Erez, Director
- ORBIMED ADVISORS LLC, Director
- Jiangsu Hengrui Pharmaceuticals Co., Ltd., 10% Owner
- Forbion Growth Opportunities Fund III Cooperatief U.A., 10% Owner